WEDGE CAPITAL MANAGEMENT L L P/NC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1015308 CHARLOTTE, NC

Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$2,589,132

+$229,489 QoQ

Shares Held

71,523

+0.2% QoQ

Ownership

0.220%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#68

of 277 holders

Holding Since

Sep 2023

8 quarters on record

Voting authority Sole 33% Shared 0% None 67%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WEDGE CAPITAL MANAGEMENT L L P/NC holds $47,806,751 across 8 Drug Manufacturers - Specialty & Generic names. COLL ranks #5 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	1,856,208	$29,476,583
2	BCRX	Biocryst Pharmaceuticals Inc	380,801	$3,808,010
3	SUPN	Supernus Pharmaceuticals, Inc.	68,885	$3,203,841
4	PBH	Prestige Consumer Healthcare Inc.	61,203	$2,893,065
5	COLL	Collegium Pharmaceutical, Inc This page	71,523	$2,589,132
6	PCRX	Pacira BioSciences, Inc.	94,554	$2,398,834
7	IRWD	Ironwood Pharmaceuticals Inc	435,650	$1,834,086
8	ANIP	Ani Pharmaceuticals Inc	19,367	$1,603,200

All Filings in COLL

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,589,132	71,523	+0.2%	Shares	Sole	2026-07-10
2026-03-31	$2,359,643	71,353	+22.5%	Shares	Sole	2026-04-13
2025-12-31	$2,697,484	58,261	+33.9%	Shares	Sole	2026-01-14
2024-09-30	$1,680,955	43,503	-5.8%	Shares	Sole	2024-10-11
2024-06-30	$1,487,801	46,205	+7.2%	Shares	Sole	2024-07-17
2024-03-31	$1,673,763	43,116	+52.8%	Shares	Sole	2024-04-23
2023-12-31	$868,488	28,216	0.0%	Shares	Sole	2024-02-01
2023-09-30	$630,627	28,216	—	Shares	Sole	2023-10-13
No filing history on record for this holder in this stock.